Nanosonics Ltd. (NAN) Shares Drop On 79% Profit Fall In FY18 Report
Jaz Harrison
August 20, 2018
Nanosonics Ltd. (ASX:NAN) released its 2018 financial results to the
Nanosonics is a medical technology company with its flagship product being the trophon EPR system. The trophon system disinfects ultrasound probes with rapid efficiency. Ultrasound probes are vitally important to hospitals and medical clinics because they are the things that radiographers and doctors use to see what’s going on inside the patient’s body. Nanosonics claims to reduce error and increase efficiency — saving clinics time and making them money.
Nanosonics Ltd. (ASX:NAN) released its 2018 financial results to the
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX:
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX:
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX:
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO),
Ultrasound probe disinfection company Nanosonics Limited (ASX: NAN) released its
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO),
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO),
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO),
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
